All terms in GO

Label Id Description
ficolin-1-rich granule membrane GO_0101003 [The lipid bilayer surrounding a ficolin-1-rich granule.]
ficolin-1-rich granule GO_0101002 [Highly exocytosable gelatinase-poor granules found in neutrophils and rich in ficolin-1. Ficolin-1 is released from neutrophil granules by stimulation with fMLP or PMA, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry.]
obsolete negative regulation of transcription from RNA polymerase II promoter in response to increased salt GO_0101008 [OBSOLETE. Any process that decreases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of detection of, or exposure to, an increase in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.]
obsolete negative regulation of transcription from RNA polymerase II promoter in response to salt stress GO_0101007 [OBSOLETE. Any process that decreases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under salt stress. The stress is usually an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.]
protein histidine phosphatase activity GO_0101006 [Catalysis of the reaction: protein histidine phosphate + H2O = protein histidine + phosphate.]
negative regulation of natural killer cell proliferation GO_0032818 [Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell proliferation.]
regulation of natural killer cell proliferation GO_0032817 [Any process that modulates the frequency, rate or extent of natural killer cell proliferation.]
negative regulation of natural killer cell activation GO_0032815 [Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell activation.]
regulation of natural killer cell activation GO_0032814 [Any process that modulates the frequency, rate or extent of natural killer cell activation.]
positive regulation of natural killer cell proliferation GO_0032819 [Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation.]
positive regulation of natural killer cell activation GO_0032816 [Any process that activates or increases the frequency, rate or extent of natural killer cell activation.]
sterol response element binding GO_0032810 [Binding to a sterol response element (SRE), a nonpalindromic sequence found in the promoters of genes involved in lipid metabolism.]
positive regulation of epinephrine secretion GO_0032812 [Any process that activates or increases the frequency, rate or extent of the regulated release of epinephrine.]
negative regulation of epinephrine secretion GO_0032811 [Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of epinephrine.]
DNA ligase IV complex GO_0032807 [A eukaryotically conserved protein complex that contains DNA ligase IV and is involved in DNA repair by non-homologous end joining; in addition to the ligase, the complex also contains XRCC4 or a homolog, e.g. Saccharomyces Lif1p.]
neuronal cell body membrane GO_0032809 [The plasma membrane of a neuron cell body - excludes the plasma membrane of cell projections such as axons and dendrites.]
lacrimal gland development GO_0032808 [The process whose specific outcome is the progression of the lacrimal gland over time, from its formation to the mature structure. The lacrimal gland produces secretions that lubricate and protect the cornea of the eye.]
obsolete receptor biosynthetic process GO_0032800 [OBSOLETE. The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.]
regulation of low-density lipoprotein particle receptor catabolic process GO_0032803 [Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein particle receptors.]
low-density lipoprotein particle receptor catabolic process GO_0032802 [The chemical reactions and pathways resulting in the breakdown of a low-density lipoprotein particle receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.]